Who owns KINNATE BIOPHARMA INC?
- CUSIP Number: 49705r105
Tip: Access positions for across all investors
Analyze quarterly positions in Kinnate Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kinnate Biopharma stock
Who bought or sold KINNATE BIOPHARMA INC this quarter?
There are no current stakeholders of Kinnate Biopharma.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Kinnate Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Mar 2024 | 1.1M | $2.9M |
| BlackRock | Mar 2024 | 431k | $1.1M |
| Goldman Sachs Group | Mar 2024 | 63k | $168k |
| Skandinaviska Enskilda Banken AB | Mar 2024 | 51k | $136k |
| Susquehanna Portfolio Strategies | Mar 2024 | 49k | $129k |
| Leucadia National Corporation | Mar 2024 | 41k | $108k |
| Northern Trust | Mar 2024 | 28k | $83k |
| Squarepoint Ops | Mar 2024 | 23k | $62k |
| Shay Capital | Mar 2024 | 19k | $52k |
| Morgan Stanley | Mar 2024 | 7.4k | $20k |
| Qube Research & Technologies | Mar 2024 | 6.3k | $17k |
| Tower Research Capital | Mar 2024 | 1.1k | $2.9k |